---

Sir Andrew Dillon

Chief Executive, UK National Institute for Health and Care Excellence (NICE)

After a successful career in hospital management Sir Andrew joined NICE – the body which determines the cost-effectiveness of new drugs for the UK National Health Service – as its founding Chief Executive in 1999. He has held this position ever since and was awarded a knighthood in 2009 for services to UK healthcare.

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016